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1. Introduction 
Each set of tRNA molecules accepting a particular 
amino acid are recognized and acylated by an amino 
acyl tRNA synthetase. This enzyme must recognize 
some feature in this set of tRNA molecules which 
distinguishes them from all other tRNAs. In this 
communication we describe the isolation and initial 
characterization of a set of E. coli tyr tRNA mutants 
that have altered amino acid specificity. These mutants 
should eventually lead to an understanding of which 
features of the tRNA are recognized by the tyrosine 
tRNA synthetase. 
Sequence analysis of one of the mutants (SU+III~-“~) 
has revealed that a single base change (A82 + G) near 
the amino acid acceptor end of the molecule is suf- 
ficient to alter its specificity. 
2. Results 
2.1. Isolation of the mutants 
The details of the isolation procedure of the mutant 
Sue111 tRNA having altered amino acid specificity will 
be described elsewhere [l] . In short, we prepared a 
hybrid phage @8OpSu’III h@*Oih susP3susR216 by 
successive crosses, replacing the right hand arm of 
$8OpSu+III with that of A carrying susP3 and susR216. 
This phage could not form plaques on non-permissive 
(Sir’) hosts, because the two amber mutations of X are 
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not suppressed by Su’III. After treating with 
N-methyl-N-nitroso-N’nitroguanidine, the lysate was 
plated on E. coli 594 (Su-) and plaques were found 
at a frequency of 10m9 - lo-” per phage particle. In 
this way we have isolated some 30 mutants, which were 
designated as ~~O~SU’III~~~, ~80pSu~IIa-*, etc. These 
mutants still maintained the characteristic feature of 
our $8OpSu’III in spontaneously losing the entire 
transducing fragment [2] including the suppressor 
gene. Thus the mutation must be located on the trans- 
ducing fragment, presumably in the Su’III gene itself. 
The suppressor must possess a new ability to suppress 
susP3 and susR216 not evident on the original Su’III 
gene. As shown in the next section, these mutants also 
show altered suppression patterns for various amber 
mutants of bacteriophage T4. 
2.2. In vivo suppression patterns of the mutant 
suppressors 
Lysogens of the mutant @8OpSu?II were formed 
in an Su- host. The various suppressors were tested for 
their ability to suppress a set of T4 amber mutants 
(table 1). We note that there are 2 sets of altered 
suppressor mutants: one set which can suppress am 
eLA3 1 and one set which cannot. am eLA3 1 is a 
mutant of T4 lysozyme in residue 105 (glutamine) 
[3,4] . About half of our mutants gained the ability 
to suppress am eLA3 1. This set of mutantsmust be 
inserting some amino acid(s) other than tyrosine in 
response to the UAG codon. Since the original h sus 
mutants used for selection do not grow on Su’III, it 
seems likely that both sets of suppressors are inserting 
amino acid(s) other than tyrosine. 
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Table 1 
Suppression of T4 amber mutants by different alleles of the SuIII gene*. 
T4 amber mutants 
lysozyme [3,4] 
---__-- ----- 
eM91 eM92 eLA3 1 eLA4 1 
rIIA [ 15, 161 
S116 S24 
5.4 
amH21 
Amino acid in wild type trp(l38) trp(158) glu(105) glu(141) trp trp ? 
Suppressor 
su- - - -5 _ _ _ 
Su+I (ser) - + + + - + + 
Su?I (glu) - + + + - +, -42” + 
Su+III (tyr) + + - + + + +, -42” 
su+Iw-1 + + - + + + +, -42” 
su+u@ + + - + 
su+w-9 t t _ + 
su+m-23 + t t + + poor i, -42” + •t 
su+w-26 •t + + + 
sU+w-30 + f + + 
-~ 
* Unless otherwise noted the suppression of T4 amber mutants was done by spot tests at 37”. 
Our suppression data with rIIA amber mutants and 
urn H2 1 suggest he following conclusions. am S 116 
can only be suppressed by the tyrosine suppressor. 
SU+III~-~ suppresses am S116 equally well indicating 
that this mutant suppressor inserts an aromatic amino 
acid. SU’III~-~” suppresses am S116 poorly so it must 
insert an aromatic amino acid but with a much lower 
efficiency. am S24 is temperature sensitive when glut- 
amine is inserted by Su+II and it is also temperature 
sensitive on Su+IIIa-23 but not on SuWI. am H21 of 
gene 54 is temperature sensitive when plated on Su’III 
or SU+III~-~ but not when plated on Su+IIIa-23. 
These data suggest hat SU’III~-*~, is capable of 
inserting an aromatic amino acid at low efficiency 
and some other amino acid(s) at higher efficiency. 
None of the T4 am mutants allow us to distinguish 
between Su’III and SU’III~-~. 
2.3, Nucleo tide sequence change in Su *IIIa-23 tRNA 
32P tRNA was prepared from cells infected with 
$~80pSu+IIIa-~~. The infection and labeling was per- 
formed as described previously [5] . The tyrosine 
tRNA was purified by benzoylated DEAE-cellulose 
chromatography, acrylamide gel electrophoresis [6] 
and DEAE-Sephadex chromatography [7] . 
The purified 32P tyr tRNA was digested with Ul 
(equivalent to Tl) ribonuclease and the products 
separated by 2-dimensional electrophoresis [8,93. 
The resulting fingerprint is shown in fig. 1. 
$~O~SU+III~-~~ carries 2 tyrosine tRNA genes [lo] . 
One is the mutated SuIII gene and the other is tyr 
tRNA I. The tyrosine tRNA should therefore be a 
mixture of altered suppressor tRNA and normal 
tyrosine tRNA I. This proved to be true. All of the UI 
oligonucleotides were eluted and characterized by 
further digestion with pancreatic ribonuclease or by 
alkaline digestion. They all proved to have identical 
composition to those of normal Su- tyr tRNA I [ 1 l] 
except for spots 3 and 17A and a third spot which is 
not seen in this fingerprint. Spot 3 contains the anti- 
codon of Su’III tRNA (CUA) running adjacent to spot 
4 which contains the normal Su- tyr tRNA anticodon 
G*UA. Spot 17A is similar to 17B, the normal 3’-end 
of the molecule which has the sequence: 
A,UC,U,CsACCACCAOH . 17A is different from 
17B in that pancreatic ribonuclease digestions of the 
oligonucleotide contain a G and 1 mole of AC instead 
of 2. The third unusual oligonucleotide seen in 
SU+III~-~~ tyr tRNA moves very slow in the first 
dimension and slightly faster than the blue dye marker 
in the second dimension. Alkali digestion of this 
oligonucleotide gives only Cp. Snake venom phospho- 
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Fig. 1. Two-dimensional oligonucleotide fingerprint of purified, RNase UI-digested tyrosine tRNA stimulated by @~O~SU+III”*~. 
Separation is by electrophoresis on cellulose acetate at pH 3.5 in 7 M urea (right to left) followed by electrophoresis on DEAE 
paper in 7% formic acid (v/v). 
diesterase digestion of the oligonucleotides gives pC 
and pA in equal molar yields. These results are 
consistent with this onligonucleotide having the 
sequence CpCpbH . 
We conclude that the mutation in SU’III~-~~ is an A 
to G transition in position 82 (fig. 2). 
Pancreatic ribonuclease digestions of the SU’III~-~~ 
tyr tRNA did not reveal any other changes although 
we acknowledge that recognition of certain changes 
could be difficult when one must recognize them 
against a background of 50% Su- tyr tRNA. At this 
point, however, there is no reason to think there is 
more than one nucleotide difference between the 
SU’III~~~ tRNA and Su’III tRNA. 
2.4. In vivo suppression assay 
We have done a considerable amount of work to 
determine the amino acid accepted in vitro by 
SU’III~-~~ tRNA. This work is being published else-, 
where [ I] . Our principal conclusion is that SU’III~~~J 
tRNA accepts glutamic acid in vitro. In this publication 
we report the results of our initial attempts to deter- 
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Fig. 2. Nucleotide sequence of Su WI tyrosine tRNA [ 71 
showing the base substitution of the mutant Su*IIW~ tRNA. 
A* is 2-methylthio-W-(AZ-isopentenul)adenosine. 
mine which amino acid is inserted by su+IIIa-23 jn viva. 
For this purpose we have employed the T4 head 
protein fingerprint assay [ 121 to determine which 
amino acid is inserted at the am H36 site [ 131. 
Lysogens carrying the wild type and mutant Su+III 
alleles were infected with T4 am H36 and the head 
protein was labelled with 14C-phenylalanine. Tryptic 
digests of the labelled head proteins produced by 
am H36 were subjected to electrophoresis at pH 6.4 
and pH 3.6 and compared with tryptic digests of wild 
type T4D, and am H36Rl (a spontaneous revertant 
of am H36 contafning tyrosine at the amber codon 
site). Wild type T4 contains glutamine in this position 
[ 131. In all cases the mobility of the tryptic peptide 
PhT12 was monitored for evidence of suppression and 
of the peptide PhT 11 for evidence of fragment produc- 
tion [ 131. It was observed that the fragment peptide 
PhT 11 was produced in comparable amounts in cells 
which contained the Su+III, SU+III~-~ and SU+III~-~~ 
alleles. In addition the mobility and amount of PhT12 
was identical when am H36 is suppressed by either 
Su+III or Su+IIIa-l . 
The suppression pattern in cells containing the 
SU+III~-~~ allele is very different. The preliminary 
results indicate that there are different versions of 
the suppressed peptide with one class migrating with 
the tyrosine-containing PhT12 and the other having 
the same mobility as the glutamine-containing PhT12. 
From electrophoretic mobilities alone we cannot 
decide what amino acid is inserted at the am H36 site 
by the mutant tRNAs. Our results are consistent with 
the following interpretation: Su+IIIa-l could be 
inserting an amino acid that gives PhT12 the same 
mobility as PhT12 containing tyrosine. Alternatively 
Su’IIIa-’ could be mainly inserting tyrosine but in 
addition could insert small amounts of some undetected 
amino acid. Su’lIIa-z3 could be inserting some 
tyrosine but it also inserts some other amino acid. 
Our results preclude the possibility that Su’IIIaz3 
could be inserting very much glutamic acid. (The in- 
sertion of an acidic amino acid would have a marked 
effect on the electrophoretic mobility of PhT12.) We 
cannot exclude the possibility that some glutamic acid 
is inserted. Clearly more work in characterizing the 
in vivo and in vitro specificity of this and other 
altered tRNAs is needed. 
3. Discussion 
We have developed a selection procedure which 
forces the Su’III suppressor to insert amino acid(s) 
different from tyrosine. The in viva suppression 
patterns of a collection of these mutants suggest hat 
they fall into at least 2 different classes. 
The sequence of the tRNA from one of the mutant 
suppressors, SU+III~-*~, contained the alteration 
A82 + G. This is identical to one of the mutants found 
by Hooper et al. [ 141. 
Apparently this single nucleotide change is 
sufficient to markedly inhibit the charging of this 
tRNA by the tyrosine tRNA synthetase and to make 
the tRNA a much better substrate for some other 
amino acyl tRNA synthetase. These results taken 
together suggest hat the stem (a) of the clover leaf 
structure could be playing an important role in the 
recognition of tRNA by amino acyl tRNA synthetase. 
This site has also been implicated as the site for IJV 
inactivation of acceptor activity of yeast alanine tRNA 
by its amino acyl tRNA synthetase [ 171. 
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